Nucleobindins

05/01/2018 - "This study was performed to study the effects of carnosine and vitamin E on tissue and serum expression of Nucleobindin 2 (NUCB2)/nesfatin-1, ghrelin, adropin, and irisin to determine whether they have protective effects in cases of ovarian torsion. "
05/01/2018 - "Effects of Carnosine and Vitamin E on Nucleobindin 2 (NUCB2)/nesfatin-1, Ghrelin, Adropin, and Irisin in Experimentally Induced Ovarian Torsion."

08/02/2021 - "According to the latest findings, nucleobindin-2/nesfatin-1 (NUCB2/NESF-1) is an important factor in cancer development and progression. "
08/02/2021 - "Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule?"
01/01/2021 - "We show that culture supernatants from tumor cells have significantly higher amounts of secreted calnuc compared to non-tumor cells, selectively packaged into exosomes. "
07/01/2017 - "In our study, nucleobindin 2 level in gastric cancer tissues was higher than in non-tumor tissues. "
01/01/2021 - "On a precise note, we propose that the molten globule structure of calnuc caused by aberrant conditions in cancer cells to be the causative mechanism underlying its exosome-mediated secretion, thereby driving metastasis."

01/01/2012 - "Nucleobindin 2 in human breast carcinoma as a potent prognostic factor."
05/24/2016 - "Recent studies indicate that a high level of nesfatin-1/Nucleobindin-2 (NUCB-2) is associated with poor outcome and promotes cell migration in breast cancer and prostate cancer. "
08/16/2013 - "Nucleobindin 2 (NUCB2) abnormal expression has been reported in gastric cancer and breast cancer. "
03/01/2014 - "Nucleobindin 2 (NUCB2) has been demonstrated to play critical roles in tumorigenesis and tumor development of breast cancer. "
07/01/2017 - "Nucleobindin 2 has been reported that its high expression is associated with poor outcome and promotes cell migration and lymph node metastasis in breast cancer, colon cancer, and prostate cancer. "

05/24/2016 - "Recent studies indicate that a high level of nesfatin-1/Nucleobindin-2 (NUCB-2) is associated with poor outcome and promotes cell migration in breast cancer and prostate cancer. "
03/01/2014 - "High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer."
07/01/2017 - "Nucleobindin 2 has been reported that its high expression is associated with poor outcome and promotes cell migration and lymph node metastasis in breast cancer, colon cancer, and prostate cancer. "
03/01/2014 - "The expression change of nucleobindin 2 at mRNA level in prostate cancer (PCa) tissues compared with adjacent benign prostate tissues was detected by using real-time quantitative reverse transcriptase-polymerase chain reaction analysis in our previous study. "

03/01/2020 - "Nucleobindin 2 (NUCB2) has been reported to play an important role in both tumorigenesis and cancer progression. "
04/01/2015 - "Nucleobindin 2 (NUCB2) has been reported to play an important role in both tumorigenesis and cancer progression. "
10/24/2022 - "Since Nucleobindin-2/nesfatin-1 is thought impact the control of a wide range of physiological processes, including energy homeostasis, neurodegenerative processes and carcinogenesis, its ligands/interactions deserve special studies and attention. "
01/01/2021 - "Exosomal calnuc is causal for epithelial-mesenchymal transition and atypical migration in non-tumor cells, which are key events in tumorigenesis and metastasis. "
03/01/2014 - "Nucleobindin 2 (NUCB2) has been demonstrated to play critical roles in tumorigenesis and tumor development of breast cancer. "